This HTML5 document contains 153 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34552924
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ vitskapeleg artikkel სამეცნიერო სტატია 2002年论文 mokslinis straipsnis 2002년 논문 2002年論文 научни чланак מאמר מדעי научни чланак artikull shkencor artykuł naukowy 2002年论文 2002年論文 bilimsel makale vědecký článek tudományos cikk مقالهٔ علمی wetenschappelijk artikel мақолаи илмӣ artigo científico (publicado na 2002) 2002年論文 سائنسی مضمون مقالة علمية 2002 թվականի մարտին հրատարակված գիտական հոդված naučni članak научна статия บทความทางวิทยาศาสตร์ 2002年論文 vetenskaplig artikel wissenschaftlicher Artikel artikulong pang-agham 2002年论文 articolo scientifico наукова стаття, опублікована в березні 2002 scienca artikolo scientific article artículo científico publicado en 2002 article scientifique (publié 2002) 2002年论文 vitenskapelig artikkel 2002 nî lūn-bûn teaduslik artikkel 2002年論文 vedecký článok article científic tieteellinen artikkeli videnskabelig artikel (udgivet 2002) 2002年论文 2002年の論文 bài báo khoa học научная статья 2002年论文 επιστημονικό άρθρο 2002 թուականի Մարտին հրատարակուած գիտական յօդուած ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico articol științific artigo científico (publicado na 2002) article scientific artículu científicu espublizáu en 2002
p:P577
wds:Q34552924-522E2352-A16A-4F49-92D1-55DFCD4F3146
wdt:P577
2002-03-01T00:00:00Z
p:P2860
wds:Q34552924-FCF67404-2120-4975-A535-7E0221CB169F wds:Q34552924-9F754AEA-D0A4-4DD2-8EC7-74966ECEC50D wds:Q34552924-A21DC0FF-8141-4472-8EA2-94CDD3BBFBAF wds:Q34552924-A78E5A6C-5DBE-4E20-AC9C-B1280D8EB95F wds:Q34552924-85AF079E-9BE6-401C-BAD8-A4F296111177 wds:Q34552924-88235178-8A6B-414B-A242-E31FBEB361CA wds:Q34552924-950042F2-9E2F-4BCE-8455-9E0E83343FBD wds:Q34552924-D85BB50C-1333-4CD2-ABEC-59A49B326443 wds:Q34552924-E47941CF-D1C8-491A-8A35-0B8C63942165 wds:Q34552924-ADDF586F-B41B-4ABD-9C54-AF2582FA873A wds:Q34552924-AE2431D2-9108-48E3-B580-4029EE96A81E wds:Q34552924-57592BA9-920F-40AF-976D-67D106283794 wds:Q34552924-39DC3D34-60EF-4733-B3CA-3D6DBAFDA27B wds:Q34552924-4B876105-7DFF-4421-83F6-4B0C75E44EAA wds:Q34552924-51245F53-E3CC-4761-91DD-479EE11AA9FC wds:Q34552924-701E9EE3-B0AC-4E99-A041-7477BEE0B7D9 wds:Q34552924-7A75E7C0-D585-49B8-974C-1773487234EB wds:Q34552924-7CD422B8-CCD8-44E6-8C3D-2C4D8E4E9DFB wds:Q34552924-5BDF5987-3261-44C6-9CAD-C3C6C4CDC869 wds:Q34552924-674D9DCF-6CF9-427C-B54D-F153A9C9A7DF wds:Q34552924-6DF774E0-7A57-4964-AE8B-B7931EECF22B wds:Q34552924-6F36F080-CD70-4AD7-ADC4-4F2434F912CE wds:Q34552924-066E7423-742A-4A4F-BA43-C4D1224D05B4 wds:Q34552924-0FB68245-B03E-4E9F-8BB5-7638B3FF7510 wds:Q34552924-E726470E-10EE-44AB-B687-FBADC673BD21 wds:Q34552924-EC3F9809-AD50-4213-9197-AB75DD9D9347 wds:Q34552924-F06E3DBF-C5C7-412B-B593-9D2DF6A0D4C0
wdt:P2860
wd:Q35611986 wd:Q72382597 wd:Q44787171 wd:Q38471168 wd:Q33500327 wd:Q68343839 wd:Q39470612 wd:Q40500303 wd:Q68583212 wd:Q68473316 wd:Q50561845 wd:Q67989907 wd:Q41318926 wd:Q69966311 wd:Q44597899 wd:Q69354861 wd:Q70376354 wd:Q41610690 wd:Q41572255 wd:Q40673230 wd:Q70590731 wd:Q44217293 wd:Q54272955 wd:Q46415035 wd:Q69580375 wd:Q36714706 wd:Q69698179
p:P2093
wds:Q34552924-832A9480-5D5B-4A6A-9756-DE5FDEB3C344 wds:Q34552924-D62861B1-3A08-4AB1-A7D1-80433E9A7EE3
wdt:P2093
Alberto E Selman Larry J Copeland
rdfs:label
Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial
skos:prefLabel
Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial
schema:name
Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial
p:P1476
wds:Q34552924-570148E1-4455-4595-B8CA-8FF95BA158A1
wdt:P1476
Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial
p:P304
wds:Q34552924-9C0E5DF7-40DB-464A-A470-BEF4682B3D66
wdt:P304
335-341
p:P31
wds:Q34552924-52ae5ae1-812f-4150-9a46-9ffdab2e828f wds:Q34552924-4BF5B286-9A8E-456A-A5B6-2F8397EA586D
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q34552924-7DE7759A-2CFD-4C18-8208-982D0B22A1F1
wdt:P921
wd:Q172341
p:P698
wds:Q34552924-BDA4C583-F470-4DEA-958D-D4D20B380BE0
wdtn:P698
n12:11880209
wdt:P698
11880209
p:P1433
wds:Q34552924-27940FD4-FAC6-45BB-A29D-C85072B5ECE6
wdt:P1433
wd:Q15724423
p:P433
wds:Q34552924-C02C4F28-35CA-45C2-8145-41D592D12484
p:P478
wds:Q34552924-06349CDB-13AF-4996-953E-2452B4CDD8F7
wdt:P433
3
wdt:P478
41
p:P356
wds:Q34552924-CA87AEA4-9E72-45A5-99AA-4E8A8EE54967
wdtn:P356
n11:S1040-8428(01)00174-3
wdt:P356
10.1016/S1040-8428(01)00174-3